Standardized Artichoke Extract: Physiological Effects, Possibilities of Use in Medical Practice
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Recently, among general practitioners – family doctors, therapists, specialists, there is a growing interest to the use of phytotherapy for the prevention and treatment of various pathologies. One of the classic examples of a medicinal plant with a long history of human use is the Spanish Artichoke.
The objective: to analyze the results of pharmacokinetic and pharmacodynamic studies of standardized artichoke extract (SAE).
Materials and methods. The review of the modern scientific literature publications about the properties of artichoke and possible areas of its use in medical practice is performed.
Results. The presented results of experimental studies confirmed that SAE is one of the safest phytopreparations, which has almost no side effects in most subjects. In a number of cases, the data of experimental pharmacology is confirmed by the results of clinical studies of evidence based medicine. Among the effects that have been established in animal models and confirmed in clinical trials should be noted: hepatoprotective, choleretic, detoxification, prebiotic, cardioprotective, lipid-lowering, nephroprotective, carcinopreventive, gravidoprotective, etc.
Conclusion. The described effects allow the use of standardized artichoke leaf extract (dried water extract of the artichoke leaves, which has a positive clinical history in both Ukraine and Europe) as an addition to the traditional therapy for the prevention and treatment of gastrointestinal pathology, kidney diseases, hypercholesterolemia and other pathology.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Kinghorn AD, Pan L, Fletcher JN, Chai H. The relevance of higher plants in lead compound discovery programs. J Nat Prod. 2011;74:1539-55. doi: 10.1021/np200391c.
Chekman IS, Horchakova NO, Kazak LI, Byelenichev IF, Bobirov VM, Vysotskyy IYU, et al. Farmakolohiia: pidruchnyk dlia stud. med ftiv. Vyd.4-te. Vinnytsia: Nova Knyha; 2017. 784 p.
Fitoterapiia v praktike sovremennogo vracha: ot problem do perspektiv. Novyny med ta farmats. 2016;5(574):19.
Lattanzio V, Paul AK, Lansalta V, Cardinali A. Globe artichoke: a functional food and source of nutraceutical ingredients. J Funct Foods. 2009;1(2):131-44. doi: 10.1016/j.jff.2009.01.002.
Petrowicz O, Gebhardt R, Donne RM, Schwandt M, Kraft K. Effects of artichoke leaf extract (ALE) on lipoprotein metabolism in vitro and in vivo. Atherosclerosis. 1997;129(1):147-50.
Chang JJ, Appl K. Radical scavenging activity and content of cynarin. Boil Chem. 2007;50:244-84.
Robards K. Strategies for determination of bioactive phenols in plants, fruit and vegetable. J Chromatgr A. 2003;1000(1-2):657-69. doi: 10.1016/s0021-9673(03)00058-x.
Zhu X, Zhang H, Lo R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J Agric Food Chem. 2004;52(24):7272-8. doi: 10.1021/jf0490192.
Pandino G, Lombardo S, Mauromicale G, Williamson G. Profile of polyphenols and phenolic acids in bracts and receptacles of globe artichoke (Cynara cardunculus var. scolymus) germplasm. J Food Compos Anal. 2011;24(2):148-53. doi: 10.1016/j.jfca.2010.04.010.
Pandino G, Lombardo S, Mauromicale G, Williamson G. Phenolic acids and flavonoids in leaf and floral stem of cultivated wild Cynara cardunculus L. genotypes. Food Chem. 2011;126(2):417-22. doi: 10.1016/j.foodchem.2010.11.001.
Gromova OA. Khofitol – standartizirovannyi ehkstrakt artishoka. Biokhimicheskii sostav I farmakologicheskie ehffekty. Trudnyi patsient. 2009;4-5:24-31.
Ceccarelli N, Curadi M, Picciarelli P, Martelloni L, Sbrana C, Giovannetti M. Globe artichoke as functional food. Mediterr J Nutr Metab. 2010;3:197-201. doi: 10.1007/s12349-010-0021-z.
Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielcka E, Horoszkiewicz-Hassan M. The influence of supplementation with artichoke (Cynara scolymus L.) extract on selected redox parameters in rowers. Int J Sport Nutr Exerc Metab.2008;18(3):313-27. doi: 10.1123/ijsnem.18.3.313.
Saenz Rodriguez T, Garcia Gimenez D, De la Puerta VR. Choleretic activity and biliary elimination of lipids and bile acids induced by anartichoke leaf extract in rats. Phytomed. 2002;9(8):687-93. doi: 10.1078/094471102321621278.
Gebhardt R. Antioxidative and protective properties of extracts from leaves of the artichoke (Cynara scolymus L.) against hydroperoxide-inducedoxidative stress in cultured rat hepatocytes. Toxicol Appl Pharmacol. 1997;144(2):279-86. doi: 10.1006/taap.1997.8130.
Brown JE, Rice-Evans CA. Luteolin-rich artichoke extract protects low-density lipoprotein from oxidation in vitro. Free Radic Res. 1998;29(3):247-55. doi: 10.1080/10715769800300281.
Salekzamani S, Ebrahimi-Mameghani M, Rezazadeh K. The antioxidant activity of artichoke (Cynara scolymus): A systematic review and meta–analysis of animal studies. Phytother Res. 2019;33(1):55-71. doi: 10.1002/ptr.6213.
Wegener T, Fintelmann V. Pharmacological properties and therapeutic profile of artichoke (Cynara scolymus L.). Wien Med Wochenschr.1999;149(8-10):241-47.
Aldasheva ZhA, Zhanuzakov MA, Mukhtarkyzy A, Abdulakimova RA, Raisova SK, Kaldybaev KZ, i dr. Ehffektivnost preparata Khofitol v kompleksnoi terapii steatozov I steatogepatitov razlichnogo geneza. Terapevticheskii Vestnik. 2010;2:79-81.
Skrypnyk IM, Detiarova II, Nevoit HV. Khofitol yak preparat vyboru v likuvanni khvorykh na khronichnyi toksychnyi hepatyt u poiednanni iz zakhvoriuvanniamy biliarnoho traktu. Klin Farmatsiia. 2004;8(3):28-30.
Konev IUV, Zhuravleva IG, Trubnikova IA. Khofitol pri khronicheskikh zabolevaniiakh gepatobiliarnoi sistemy u pozhilykh. Klin Gerontol. 2007;1:57-60.
Kraft K. Artichoke leaf extract – recent findings reflecting effects on lipid metabolism, liver, and gastrointestinal tracts. Phytomed. 1997;4(4):69-78. doi: 10.1016/S0944-7113(97)80049-9.
Loranskaia ID, Rakitskaia LG, Mamedova LD. Vozmozhnosti primeneniia ekstrakta artishoka u bolnykh khronicheskim alkogolnym gepatitom. Rossiiskii Zhurn Gastroehnterol, Gepatol, Kolopraktol. 2005;15(3):82.
Matuschowski JP. Testing of Cynara scolymus in the isolated perfused rat liver. 43rd Ann Congr Soc Med Plant Res.1996;10:103-7.
Khopta NS. Stan kistkovoi tkanyny shchuriv za umov nadkhodzhennia nitrytiv ta korektsiia porushen ekstraktom artyshoku. Biolohiia Tvaryn. 2015;17(3):124-31.
Fintelman V. Therapeutic profile and mechanism of action ofartichoke leaf extract: hypolipemic, antioxidant, hepatoprotective and choleretic properties. Phytomed. 1996;201:50-60.
Gebhardt R. Inhibition of hepatic cholesterol biosynthesis by artichoke leaf extracts is mainly due to luteolin. Cell Biol Toxicol. 1996;10:89-150.
Gromova OA. KhofitoL – standartizirovannyi ehkstrakt artishoka. Biokhimicheskii sostav ifarmakologicheskie ehffekty. Trudnyi Patsient. 2009;4-5:24-31.
Valerio F, De Bellis P, Lonigro SL, Morelli L, Visconti A, Lavermicocca P. In vitro and in vivo survival and transit tolerance of potentially probiotic strains carried by artichokes in the gastrointestinal tract. Appl Environ Microbiol.2006;72(4):3042-45. 10.1128/AEM.72.4.3042-3045.2006.
Panova LD, Bulatova ST, Akhmetkhanova RR. Primenenie rastitelnogo preparata Khofitol v kompleksnoi terapii zatiazhnykh neonatalnykh zheltukh s nepriamoi bilirubinemiei. Med Alfavіt: Prakt Gastroenterol. 2018;7(1):5-8.
Samochowiec L. Investigations on experimental atherosclerosis. Part XV. The effect of Cynara scolymus L and Cynara cardunculus L on the development of experimental atherosclerosis in white rats Dissertationes. Pharmaceutica. 1959;11:99-113.
Ben Salem M, Affes H, Dhouibi R, Charfi S, Turki M, Hammami S, et al. Effect of Artichoke (cynara scolymus) on cardiac markers, lipid profile and antioxidants levels in tissue of HFD-induced obesity. Arch Physiol Biochem. 2019;28:1-11. doi: 10.1080/13813455.2019.1670213.
Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HC. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomed. 2008;15(9):668-75. doi: 10.1016/j.phymed.2008.03.001.
Englisch W, Beckers C, Unkauf M, Ruepp M, Zinserling V. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschun. 2000;50(3):260-65. doi: 10.1055/s-0031-1300196.
Lupattelli G, Marchesi S, Lombardini R, Roscini AR, Trinca F, Gemelli F, et al. Artichoke juice improves endothelial function in hyperlipemia. Life Sci. 2004;76(7):775-82. doi: 10.1016/j.lfs.2004.07.018.
Santos HO, Bueno AA, Mota JF. The effect of artichoke on lipid profile: A review of possible mechanisms of action. Pharmacol Res. 2018;137:170-78. doi: 10.1016/j.phrs.2018.10.007.
Nadova E, Miadokova P, Mucaji D, Grancai LC. Growth inhibitory effect of ethyl acetate–soluble fraction of Cynara cardunculus L. in leukemia cells involves cell arrest, cytochrome c release and activiation of caspases. Phytother Res. 2008;22(2):165-800. doi: 10.1002/ptr.2263.
Villarini M, Acito M, Di Vito R, Vannini S, Dominici L, Fatigoni C, et al. Pro-Apoptotic Activity of Artichoke Leaf Extracts in Human HT–29 and RKO Colon Cancer Cells. Int J Environ Res Public Health. 2021;18(8):4166. doi: 10.3390/ijerph18084166.
Khattab HA, Wazzan MA, Al-Ahdab MA. Nephroprotective potential of artichoke leaves extract against gentamicin in rats: Antioxidant mechanisms. Pak J Pharm Sci. 2016;29(5 Suppl):1775-82.
Sukalo AV, Kozyro IA, Belkevich AG, Tur NI, Borycheva AA. Ispolzovanie preparata khofitol v kompleksnoi terapii khronicheskoi pochechnoi nedostatochnosti. Retsept. 2019;4:647-52.
Mamaeva MA. Sovremennye fitopreparaty v terapii sochetannoi patologii organov mochevoi sistemy i pishchevaritelnogo trakta u detei. Ross Vestnik Perinatol i Pediatr. 2004;2:15.
Ryzhenko IM, Asadulaieva NIa, Zaichenko HV, Sakharova TS. Doslidzhennia hravidoprotektornoi aktyvnosti ekstraktu artyshoku polovoho v umovakh serotoninovoi platsentarnoi dysfunktsii. Klin Farmatsiia. 2011;15(1):22-5.
Murashko LE. Primenenie khofitola pri beremennosti. Probl Beremennosti. 2000;1:69.
Logutova LS, Novikova SV. Primenenie khofitola dlia profilaktiki platsentarnoi nedostatochnosti u beremennykh gruppy vysokogo perinatalnogo riska. Ross Vestnik Akushera-Ginekologa. 2004;4(5):44.
Striuk RI, Travnikova NL, Pavlova LN, Sokolova EV, i dr. Klinicheskaia effektivnost Khofitola pri platsentarnoi nedostatochnosti u beremennykh s zabolevaniiami serdechno-sosudistoi sistemy. Prakt Vrach. 2004;5:47-9.
Begova SV. Ehffektivnost pregravidarnoi podgotovki mnogorozhavshikh zhenshchin s gestozom tiazheloi stepeni i ZHDA. Voprosy Ginekol, Akusherstva i Perinatol. 2006;5(5):11-6.
Kulagina NB, Semenova ED, Popova SS. Kompleksnoe lechenie giperplasticheskikh protsessov v ehndometrii u zhenshchin s miomoi matki. Ross Vestnik Akushera-Ginekol. 2006;6(1):41.
Chereiskaia NK, Shapovalenko SA, Shuganov EG, Zhakova II. Korrektsiia metabolicheskikh narushenii u zhenshchin perimenopauzalnogo perioda. Vestnik Ross Assots Akusherov-Ginekol. 2000;4:44.
Awad OME, El-Sohaimy SA, Ghareeb DA, Aboulenein AM, Saleh SR, El-Aziz NMA. Phytochemical Analysis and Toxicity Assessment of Artichoke By-product Extract. Pak J Biol Sci. 2020;23(1):81-91. doi: 10.3923/pjbs.2020.81.91.
Ahmadi A, Heidarian E, Ghatreh-Samani K. Modulatory effects of artichoke (Cynara scolymus L.) leaf extract against oxidative stress and hepatic TNF-α gene expression in acute diazinon-induced liver injury in rats. J Basic Clin Physiol Pharmacol. 2019;30(5). doi: 10.1515/jbcpp-2018-0180.
Hemati N, Venkatakrishnan K, Yarmohammadi S, Moradi M, Moravejolahkami AR, Hadi A. The effects of supplementation with Cynara scolymus L. on anthropometric indices: А systematic review and dose-response meta-analysis of clinical trials. Complement Ther Med. 2021;56:102612. doi: 10.1016/j.ctim.2020.102612.
